Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
POLITICO: House Judiciary Tees Up IP Hearing
The House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence and the Internet is scheduled to hold a hearing June 4 to discuss balancing innovation and access for medicines and intellectual property, according to the House Committee Repository. Last week, Patients For Affordable Drugs Now, AARP, and The ERISA Industry Committee wrote to congressional leadership […]
News and Reports
Epoch Times: Your Prescription May Cost Less Than You Think
Still, those fixes depend on patients knowing where to look and having the time and energy to keep looking. Patients for Affordable Drugs Now said that such tools help in the short term but that they do not solve the underlying problem: the price of the drug itself. “Americans know that high drug prices are […]
News and Reports
STAT News: Trump’s drug-pricing deals set to be tested by new product launches
Alyson Bancroft, the director of legislation, policy, and alliances at Patients for Affordable Drugs Now, said the secretiveness of the White House deals makes it impossible to tell which drugs are covered. “At their core, the MFN deals between the administration and pharmaceutical companies are voluntary agreements that lack meaningful implementation or enforcement mechanisms,” Bancroft […]
News and Reports
The Epoch Times: The Loophole Drug Makers Use to Keep Prices High
Bob Parant left his home on Long Island for the first time when he enrolled in college. Always interested in sports, he decided to try out for the football team in his sophomore year. One day, Parant got a message to report to the athletic office. “The coach calls me in and says, ‘You’ve got […]
News and Reports
The Epoch Times: The Loophole Drug Makers Use to Keep Prices High
News and Reports
AARP: Supreme Court Rejects Drugmakers’ Challenge to Medicare Price Negotiations
Their “denial of these petitions brings an end to these six companies’ efforts to dismantle the Medicare Negotiation program,” says Michael Lieberman, counsel for Patients For Affordable Drugs at Fairmark Partners LLP. “Six of the largest pharmaceutical companies in the world, represented by some of the largest law firms in the world, raised a wide […]
News and Reports
Healthcare Finance: Supreme Court declines to hear drugmakers' challenge to price negotiations
Negotiated prices are projected to save 9 million people on Medicare $1.5 billion in out-of-pocket costs, while saving taxpayers $6 billion in 2026 alone, according to Patients For Affordable Drugs.
News and Reports
Epoch Times: Supreme Court Rejects Pharma Challenge to Medicare Price Negotiations
“They raised a variety of arguments challenging the program as a whole,” said Michael Lieberman, attorney at Fairmark Partners LLP, who had filed amicus briefs concerning the lawsuits. The drug makers based their arguments on the First Amendment, the Fifth Amendment’s takings clause, the Eighth Amendment’s prohibition on excessive fines, and due process arguments, Lieberman […]